1. Market Research
  2. > Biotechnology
  3. > Genomics Proteomics and Enabling Technology Market Trends
Cancer Biomarkers Market to 2027 - Global Analysis and Forecasts By Biomarker Type; Profiling Technology; Cancer Type; Application and Geography

Cancer Biomarkers Market to 2027 - Global Analysis and Forecasts By Biomarker Type; Profiling Technology; Cancer Type; Application and Geography

  • October 2019
  • 241 pages
  • ID: 5828363
  • Format: PDF
  • The Insight Partners

Summary

Table of Contents

Search Inside

The global cancer biomarkers market is expected to reach US$ 31,206.00 Mn in 2027 from US$ 12,175.69 in 2018. The market is estimated to grow with a CAGR of 11.1% from 2019-2027.
Driving factors such as growing cancer prevalence across the globe, new product launches and FDA approvals, and technological advancements are expected to boost the market over the years.However unfavorable regulatory and reimbursement scenario is likely to have a negative impact on the growth of the market in the coming years.

Besides, the development opportunities in emerging countries are likely to have a positive effect on the growth of the market in the forecast years.
Cancer immunotherapies are rapidly replacing traditional treatment standards and expanding the therapeutic landscape for cancer patients.Researchers are focused on finding molecules in the blood that can signal the appearance of cancers.

For the diagnosis of ovarian and prostate cancers, the cancer antigen (CA)125 and prostate-specific antigen (PSA) are used alongside other tests. Additionally, advancements in high-throughput omics technologies, including genomics, proteomics, transcriptomics, and metabolomics, has accelerated the pace of biomarker discovery.
The emerging markets like the Asia Pacific are creating better opportunities for significant market players to expand their business.This is a prime reason for market growth in the forecast period.

Most of the major players focus on emerging countries such as India, China, and others owing to a large number of cancer patients and growing medical tourism in developing countries. Most of the emerging countries are preferred place for medical tourism. As per the Australian Institute of Health and Welfare, 140,000 new cases of cancer are diagnosed in 2018 and the low cost of surgeries, advanced technologies with less waiting time for procedures in the region is likely to boost the demand for cancer biomarkers
In 2018, the breast cancer segment accounted for the largest market share in the global cancer biomarkers market by the cancer type segment.The biological features of the tumor used for estimating diagnosis and select suitable therapy for patients with breast cancer.

HER2 is a growth factor receptor present on the surface of breast cells.Approximately 30% of breast cancer patients have tumors, which expresses a large amount of HER2.

Various anti-cancer drugs are targeted for protein, making an accurate determination of the presence or absence of the protein in a tumor a vital step in calculating the proper treatment. At present, the cases of cancer are increasing across the globe.
The global cancer biomarkers market is segmented by biomarker type, profiling technology, cancer type, application, and end-user.On the basis of product, the market is segmented into antibodies, equipment, reagents, and kits.

On the basis of cancer type, the market is segmented into breast cancer, lung cancer, prostate cancer, leukemia, bladder cancer, and other cancer types.Based on application, the market is segmented into diagnostics, research and development, prognostics, and other applications.

On the basis of biomarker type, the market is segmented into genetic biomarkers, protein biomarkers and other cancer biomarkers. On the basis of profiling technology, the market is segmented into omics technologies, imaging technologies, immunoassays, cytogenetics, and bioinformatics.
Some of the important primary and secondary sources included in the report are, Food and Drug Administration, World Health Organization (WHO), Cancer Association of South Africa (CANSA), National Institute of Cancer Prevention and Research (NICPR), National Cancer Institute, Canadian Institutes of Health Research (CIHR),

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Biomarkers Market - Growth, Trends, COVID-19 Impact, and Forecast (2021 - 2026)

  • $ 4250
  • September 2021
  • 155 pages

The biomarker market was valued at approximately USD 41.49 billion in 2020, and it is expected to witness a revenue of USD 90.21 billion in 2026, with a CAGR of 13.76% over the forecast period. The COVID-19 ...

  • World
  • Biomarker
  • Industry analysis
  • Health Expenditure
  • Cancer Incidence

ref:plp2019

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on